Dorsey Wright & Associates’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-21,251
Closed -$2.29K 317
2021
Q1
$2.29K Buy
21,251
+436
+2% +$48.4K 0.03% 242
2020
Q4
$2.44M Buy
20,815
+869
+4% +$88.5K 0.36% 84
2020
Q3
$1.71M Sell
19,946
-1,955
-9% -$167K 0.31% 94
2020
Q2
$1.73M Sell
21,901
-81
-0.4% -$6.32K 0.35% 88
2020
Q1
$1.67M Buy
+21,982
New +$1.73M 0.63% 77
2013
Q3
Sell
-29,714
Closed -$1.79M 104
2013
Q2
$1.79M Buy
+29,714
New +$1.86M 0.29% 38

Other funds holding DVA

Dorsey Wright & Associates's DVA Position: Q2 2021 in Review

Dorsey Wright & Associates sold out of DaVita (DVA) in Q2 2021, closing a stake of 21,251 shares — an estimated $2.29K sold.

Dorsey Wright & Associates first reported a position in DVA in Q2 2013 and held it in 6 quarters. The position peaked at $2.44M in Q4 2020. 515 funds tracked by Wall St. Rank hold DVA as of Q2 2021.

  • Dorsey Wright & Associates reported no remaining DaVita position as of Q2 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 21,251 DaVita shares in Q2 2021, an estimated $2.29K.
  • Dorsey Wright & Associates first reported a position in DaVita in Q2 2013 and held it in 6 quarters.
  • Dorsey Wright & Associates's DaVita position peaked at $2.44M in Q4 2020.
  • 515 funds tracked by Wall St. Rank held DaVita as of Q2 2021.

Based on Dorsey Wright & Associates's 13F filing for Q2 2021, filed 23 Jul 2021.